Sorbent hemoperfusion in end-stage renal disease: An in-depth review

James F. Winchester, Claudio Ronco

Research output: Contribution to journalReview articlepeer-review

31 Scopus citations


The excessive mortality in dialysis patients has rekindled interest in research of adsorbent removal of nontraditional uremic toxins. Middle-molecular-weight substances, predominantly small proteins, have been correlated with specific uremic syndromes and implicated in the uremic state. New developments in polymer technology and carbon pyrrolization techniques have produced sorbents possessing mesopores of sufficient size to trap middle-molecular-weight substances. Clinical application of hemoperfusion devices containing these sorbents is early in its development. Studies related to hemoperfusion in uremia are discussed in detail.

Original languageEnglish
Pages (from-to)19-25
Number of pages7
JournalAdvances in Renal Replacement Therapy
Issue number1
StatePublished - 2002
Externally publishedYes


  • Hemodialysis
  • Mesopores
  • Middle-molecular-weight toxius
  • Sorbents
  • Uremia


Dive into the research topics of 'Sorbent hemoperfusion in end-stage renal disease: An in-depth review'. Together they form a unique fingerprint.

Cite this